Comparative Pharmacodynamics and Antimutant Potentials of Doripenem and Imipenem with Ciprofloxacin-Resistant Pseudomonas aeruginosa in an In Vitro Model
- 1 March 2012
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (3) , 1223-1228
Abstract
To compare the antipseudomonal efficacy of doripenem and imipenem as well as their abilities to restrict the enrichment of resistant Pseudomonas aeruginosa , multiple-dosing regimens of each drug were simulated at comparable values of the cumulative percentages of a 24-h period that the drug concentration exceeds the MIC under steady-state pharmacokinetic conditions ( T >MIC ) and ratios of the 24-hour area under the curve (AUC 24 ) to the MIC. Three clinical isolates of ciprofloxacin-resistant P. aeruginosa (MIC of doripenem, 1 μg/ml; MICs of imipenem, 1, 2, and 2 μg/ml) were exposed to thrice-daily doripenem or imipenem for 3 days at AUC 24 /MIC ratios of from 50 to 170 h (doripenem) and from 30 to 140 h (imipenem). The antimicrobial effects for susceptible and resistant subpopulations of bacteria were expressed by the areas between control growth and time-kill curves ( I E s) and areas under the bacterial mutant concentration curves (AUBC M s), respectively. With each antibiotic, the I E and AUBC M versus log AUC 24 /MIC relationships were bacterial strain independent. At similar AUC 24 /MIC ratios, doripenem was slightly less efficient than imipenem against susceptible and resistant subpopulations of bacteria. However, doripenem appeared to be somewhat more efficient than imipenem at clinically achievable AUC 24 s related to the means of the MICs for the three studied strains and had higher antimutant potentials for two of the three strains.Keywords
This publication has 20 references indexed in Scilit:
- Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenemJournal of Antimicrobial Chemotherapy, 2010
- Influence of Empiric Therapy with a β-Lactam Alone or Combined with an Aminoglycoside on Prognosis of Bacteremia Due to Gram-Negative MicroorganismsAntimicrobial Agents and Chemotherapy, 2010
- Impact of Different Carbapenems and Regimens of Administration on Resistance Emergence for Three Isogenic Pseudomonas aeruginosa Strains with Differing Mechanisms of ResistanceAntimicrobial Agents and Chemotherapy, 2010
- Hospital-Acquired Infections Due to Gram-Negative BacteriaNew England Journal of Medicine, 2010
- Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumoniaJournal of Medical Economics, 2009
- DoripenemClinical Infectious Diseases, 2009
- Enrichment of Fluoroquinolone-Resistant Staphylococcus aureus : Oscillating Ciprofloxacin Concentrations Simulated at the Upper and Lower Portions of the Mutant Selection WindowAntimicrobial Agents and Chemotherapy, 2008
- Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*Critical Care Medicine, 2008
- Comparative Review of the CarbapenemsDrugs, 2007
- Overview of Nosocomial Infections Caused by Gram-Negative BacilliClinical Infectious Diseases, 2005